Day: March 11, 2026

Amneal Pharmaceuticals (NASDAQ:AMRX) used a recent investor presentation to highlight momentum coming out of fiscal 2025 and outline priorities for 2026 and beyond, emphasizing growth drivers across its Affordable Medicines business, specialty portfolio, and its AvKARE distribution unit.